Vermont's Attorney General has sued the Sackler family, owners of Purdue Pharma, for allegedly directing a deceptive opioid marketing campain; drug manufacturer Eli Lilly has offered a half-priced, generic version of Humalog insulin; asthma rates for children fell in Los Angeles after air quality improved.
Vermont’s Attorney General T.J. Donovan has sued 8 members of the Sackler family, owners of the company that manufactures OxyContin, CNN reported. Donovan has accused the family members of directing a marketing campaign that minimized the health risks of opioids and encouraged sales representatives to promote higher-dose products, which were more addictive and dangerous. The Sacklers and their company, Purdue Pharma, have denied the allegations and plans to mount a defense.Fulfilling a promise made in March to offer more affordable insulin for patients with diabetes, drug manufacturer Eli Lilly is now selling a half-priced, generic version of Humalog called insulin lispro, Associated Press reported. Lilly said patients who have high-deductible health insurance, are uninsured, or have Medicare Part D plans will experience the greatest cost-savings. The average price of insulin almost tripled from 2002 to 2013 and has risen about 10% per year since then. The generic version will cost about $137.50 per vial or $265.20 for a package of 5 pens, an easier-to-inject option.Improvements in Los Angeles’ air quality have resulted in fewer children being diagnosed with asthma, according to NPR. Researchers at the University of Southern California conducted a study to examine whether stricter regulation of vehicle emissions that improved air quality could lead to better health outcomes. The findings were published yesterday in JAMA, and while they didn’t establish a cause and effect relationship, they provided convincing circumstantial evidence that improvements in air quality could result in fewer illnesses.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen